Lineage priming suggests that the stem cells activate specific genes associated with their differentiated progeny before they commit to differentiate.
The therapeutic potential of stem cells or their differentiated progenies will depend on their capacity to differentiate into mature and functional cell types after transplantation.
They also tend to lose their differentiated properties and transform into the neoplastic state.
Human embryonic stem cells (hESC) and their differentiated progenies are an attractive cell source for transplantation therapy and tissue engineering.
In some neurological diseases the transplantation of stem cells or their differentiated derivatives, such as NPCs, can cause functional improvement by replacing lost cell, particularly neurons.
Based on this, it is clear that separation of hESC-CICs, apart from their differentiated derivatives, will be essential in future studies involving their molecular regulation.
Compared to their differentiated progeny, stem cells are often characterized by distinct metabolic landscapes that emphasize anaerobic glycolysis and a lower fraction of mitochondrial carbohydrate oxidation.
Stem cells and their differentiated progeny offer great hope for treating disease by providing an unlimited source of cells for repairing or replacing damaged tissue.
Genomic editing of hPSCs and their differentiated cells broadens the use of the hPSC paradigm in studying human cellular function and disease as well as developing therapeutics.
We therefore investigated adhesion, cytoarchitecture and activation status of primary human monocytes and their differentiated derivatives, macrophages, on diamond-like coated glass coverslips using immunofluorescence technique.
Thus, IPC scaffolds offered a promising platform for the presentation of signals to cells, in this case, to influence their differentiated function.
